日本针对抗药性细菌进行个性化菌体治疗的可行性研究
Kayoko Hayakawa1, Kotaro Kiga2, Shinjiro Ojima2
1Department of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan.
概括
这项试点研究证明了在日本为治疗耐药细菌感染准备个性化菌体的可行性. 这些发现支持未来针对个性化菌体治疗的临床试验.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 个性化菌体疗法是欧洲和美国治疗难治细菌感染的既定治疗方法.
- 耐药细菌对全球健康构成重大挑战,需要新的治疗方法.
- 目前日本缺乏针对个性化菌体治疗的确立临床试验.
研究的目的:
- 评估在日本为治疗耐药细菌感染准备个性化菌体的可行性.
- 收集初步数据,用于在日本设计未来的菌体治疗临床试验.
主要方法:
- 一项观察性研究涉及30名患有耐治疗细菌感染的成年患者.
- 从环境来源和现有图书馆中识别和分离活性菌体.
- 准备具有高位数 (≥10^8 PFU/ml) 的菌体对抗患者衍生细菌菌株.
主要成果:
- 对86.7%的细菌菌株 (26/30) 成功准备了个性化菌体.
- 常见的细菌包括耐甲基金色葡萄球菌 (MRSA) 和耐卡巴胺的空气菌 (CRPA).
- 与MRSA和NTM相比,对CRPA的菌体更容易从环境中分离出来.
结论:
- 个性化菌体准备对于难以治疗的耐药细菌感染是可行的.
- 该研究提供了关键数据,支持在日本启动个性化菌体治疗的临床试验.
相关概念视频
Lytic Cycle of Bacteriophages
72.2K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
72.2K
Microorganisms in Medicine and Therapeutics
349
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
349
DNA Bacteriophages
160
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
160
Development of Antibiotic Resistance
219
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
219
Lysogenic Cycle of Bacteriophages
63.3K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
63.3K


